Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2017 Aug 14, 2017
Moleculin Begins Clinical Testing Site Development Efforts in Poland; Selects Bioscience SA as Polish CRO Aug 3, 2017
Moleculin's New Drug for the Treatment of Glioblastoma Nears Clinical Trials at MD Anderson Cancer Center Jul 25, 2017
Moleculin Appoints Lead European Principal Investigator for Planned Annamycin Clinical Trial Jul 6, 2017
Reminder: Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update Jun 29, 2017
